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Abstract Humans have evolved alongside infectious dis-
eases for millennia. Despite the efforts to reduce their inci-
dence, infectious diseases still pose a tremendous threat to
the world population. Fast development of molecular tech-
niques and increasing risk of new epidemics have resulted in
several studies that look to the past in order to investigate the
origin and evolution of infectious diseases. Tuberculosis and
leprosy have become frequent targets of such studies, owing
to the persistence of their molecular biomarkers in ancient
material and the characteristic skeletal lesions each disease
may cause. This review examines the molecular methods used
to screen for the presence of M. tuberculosis and M. leprae
ancient DNA (aDNA) and their differentiation in ancient hu-
man remains. Examples of recent studies, mainly from Eu-
rope, that employ the newest techniques of molecular analysis
are also described. Moreover, we present a specific approach
based on assessing the likely immunological profile of historic
populations, in order to further elucidate the influence of
M. tuberculosis and M. leprae on historical human
populations.
Introduction
Infectious diseases such as tuberculosis, plague, leprosy and
cholera have accompanied humans since the dawn of our his-
tory. The past is marked by epidemics and pandemics that
have influenced all aspects of human life. Scientific discover-
ies and significant development of techniques of molecular
biology in recent years have caused increasing interest in in-
vestigating the origins and history of infectious diseases and
their agents. Studying ancient diseases is essential for under-
standing microbial evolution, spread, and confirmation of ep-
idemics and pandemics. Tuberculosis and leprosy are among
the diseases that arouse the greatest interest in paleopatholo-
gists, as theymay leave characteristic lesions on the bones that
suggest a diagnosis based on bone morphology. In
osteoarticular tuberculosis, skeletal lesions are most often
found in the thoracic and lumbar vertebrae, as well as hip
and knee joints. Tuberculosis can also attack the epiphysis
and metaphysis of the long bones (Fig. 1a–c). Lesions on
the internal surface of ribs are another indicator of possible
skeletal tuberculosis but do not provide firm identification
[1, 2]. Changes considered as indicative of leprosy include
the rhinomaxillary syndrome (Facies leprosa) (Fig. 1d) and
lesions of the hand, foot, tibia and fibula (Fig. 1e). New bone
formation in the peritoneum of tibia and fibula alone are not
accepted as criteria for leprosy diagnosis due to the fact that a
number of conditions can cause those changes [2, 3].
Both tuberculosis and leprosy are caused by mycobacteria,
which have characteristic, lipid-rich thick cell walls that are
less susceptible to degradation [5] and can be detected direct-
ly, without amplification [6, 7]. These lipid biomarkers are
totally distinct from anything found in mammalian tissue
and are specific for members of the Mycobacterium
tuberculosis complex (MTBC) or M. leprae, so enable inde-
pendent identification of these pathogens in ancient material at
* H. W. Witas
henryk.witas@umed.lodz.pl
1 Department of Molecular Biology, Medical University of Łódź,
Łódź, Poland
2 Division of Infection and Immunity, University College London,
London, UK
3 Retired professor, Marusarzówny, Gdańsk, Poland
Eur J Clin Microbiol Infect Dis (2015) 34:1733–1749
DOI 10.1007/s10096-015-2427-5
the molecular level. Molecular markers not only allow the
verification of paleopathological diagnoses but also enable
individuals with ambiguous or no visible lesions to be
screened for the presence of bacterial biomolecular markers,
since, in the majority of tuberculosis and leprosy cases, there
are no visible bone changes [8, 9].
Tuberculosis and leprosy are fatal diseases that still cause
deaths in both developed and developing countries. It is a
curable and preventable disease that most often affects lungs,
caused by members of a group of closely related bacterial
species, which comprise the MTBC. It is the greatest killer
worldwide due to a single infectious agent. Data obtained
from 202 countries and territories show that, in 2013, 9.0
million people were infected withM. tuberculosis, 1.5 million
died because of tuberculosis, while about one-third of the
world’s population has latent tuberculosis [10]. Leprosy is a
curable, chronic disease caused by Mycobacterium leprae.
This disease mainly affects skin, peripheral nerves, mucosa
of the upper respiratory tract and eyes. According to official
data from 102 countries, 215,656 new cases of leprosy were
reported in 2013 [11] and it is still the greatest cause of
infection-related disability in the world.
The earliest known paleopathological evidence of human
tuberculosis was found in ancient Syria at around the time
(8800–7600 BC) of animal domestication [12]. Before this
study, the earliest evidence was from two Neolithic individ-
uals (7000 BC) in the Eastern Mediterranean [13]. Other
ancient cases of tuberculosis described in the literature include
a 5400–4800 BC case from central Germany [14], a 5000 BC
case fromHungary [6] and a 4000 BC case from Italy [15, 16].
The first molecular studies of ancient infectious diseases used
the method of collecting samples and testing for the presence
of MTBC ancient DNA (aDNA) described by Spigelman and
Lemma [17]. In 1994, the first report of tuberculosis based on
tissue from a pre-Columbian Peruvian mummy was pub-
lished, including confirmatory aDNA cloning and sequencing
[18]. The earliest known paleopathological evidence of lepro-
sy came from India from the post-urban phase of the Indus
Age [19]. A number of other ancient cases of leprosy have
been described in the literature, including a 4th–3rd century
BC case from Bologna, northeastern Italy [20], a 4th century
BC–3rd century AD case from Thailand [21] and a 3rd cen-
tury BC case from Britain [22]. The first molecular evidence
of M. leprae was published in 1994 [23, 24] and the oldest
sample confirmed by polymerase chain reaction (PCR) was
from the 1st century AD [25]. The present article is a review of
methods used for the identification and differentiation of the
MTBC and M. leprae DNA in ancient human remains. Fur-
thermore, we present a number of tuberculosis and leprosy
cases, mainly from Europe, in samples recently excavated
from archaeological sites and those housed in museum collec-
tions that have been subjected to molecular analysis. Finally,
we propose further approaches for assessing the possible pres-
ence of bacteria and their influence on ancient humans, mainly
Fig. 1 Lesions typical of
tuberculosis: a defects of
proximal epiphysis of the tibia
seen from above, b distorted
distal end of the femur
(Sypniewo, northeast Poland), c
changes of the distal end of the
left forearm and carpus (Ołbin in
Wrocław, southwest Poland);
lesions typical of leprosy: d
defects in the palate, e fusion of
the Lisfranc joint and atrophy of
the first metatarsal bone (Suraż,
northeast Poland) [4]
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by estimation of the immunological profiles of historic
populations.
Methods of molecular identification
and differentiation ofM. tuberculosis and M. leprae
Properties of aDNA
Spontaneous hydrolysis and oxidation are examples of the
most commonly found damage that cause post mortem insta-
bility of nucleic acids. DNA decay typically demonstrates
baseless sites, double- and single-strand breaks, miscoding
lesions and cross-links [26–29], although the relative rates of
different kinds of aDNA damage and their mode of accumu-
lation vary between specimens under different environmental
conditions [30]. Since it is almost impossible to retrieve long
amplification products of aDNA, researchers focus on short
sequences, around 100–200 base pairs (bp), and repetitive
regions. Real-time PCR, based on the incorporation of fluo-
rescent markers into double-stranded DNA, is especially use-
ful in this kind of research because of the ability to target
shorter regions that can be visualised on screen instead of on
a gel. Genomic deletions can be examined by PCR followed
by gel electrophoresis. Detection of single nucleotide poly-
morphisms (SNPs) by PCR-restriction fragment length poly-
morphism (PCR-RFLP) analysis is based on sequencing of
the PCR product or its digestion with a restriction enzyme
and subsequent gel electrophoresis. The problems arising
from degradation and contamination of the samples are much
reduced in methodology such as next-generation sequencing
(NGS) [31] or whole-genome sequencing (WGS) [32]. In
NGS, selective enrichment of target DNA can be achieved
by the use of microarrays or bead suspensions that are able
to bind specific target sequences. An alternative approach in
WGS is ‘shotgun’ sequencing, where every DNA fragment is
tagged and sequenced. Thereafter, high-throughput sequenc-
ing and bioinformatic analysis is performed [33, 34].
Molecular identification and differentiation of the MTBC
and M. tuberculosis
TheMTBC consists of a group of very closely related species,
includingM. tuberculosis,M. africanum,M. bovis,M.microti,
M. pinnipedii andM. canettii [35, 36] that cause infections in
humans and animals. Identification of the MTBC at the spe-
cies level, as well as differentiation of M. tuberculosis geno-
types derived from skeletal samples, may be performed using
the molecular methods described below. In the MTBC, there
are specific regions of the repetitive element IS6110 that can
identify these pathogenic lineages. In human M. tuberculosis,
the number of copies of IS6110 varies between strains, from 0
in rare strains from Southeast Asia to 24 copies/cell, while in
other members of the MTBC, there is only one copy of this
element per cell [37]. The specific IS6110 primers have been
used frequently as a marker of the presence of MTBC DNA
but it has long been known that different regions of this repet-
itive element have been detected in mycobacteria other than
tuberculosis [38]. The repetitive element IS1081 is also used
to detect DNA from the MTBC and, as there are normally six
copies per cell, it has been used for quantitative analysis and
for the detection ofM. bovis [39]. Other examples used for the
detection of the MTBC include specific sites in the RNA
polymerase beta gene (rpoB) and 19 kDa antigen gene
[40–42]. Evolutionary ‘modern’ and ‘ancient’ strains of
M. tuberculosis can be distinguished by analysis of the
M. tuberculosis-specific D1 deletion site (Fig. 2). Loss of the
TbD1 region is common in strains from all three major groups
ofM. tuberculosis described by Sreevatsan et al. [43], in con-
trast to all strains ofM. bovis and in a part of the early group 1
lineage of M. tuberculosis [44].
Since the entire genome of M. tuberculosis and M. bovis
have been sequenced, there is a wide choice of genetic sites
that can be used to distinguish between these species. For
example, M. tuberculosis and M. bovis can be distinguished
fromM. bovis based on the deletion region RD2 (now known
as RD7) that is absent in M. bovis [45, 46]. Spoligotyping
(spacer oligonucleotide typing) is based on the variation of
the direct-repeat (DR) locus found in the members of the
MTBC that enables the differentiation of the members of the
MTBC and identification of M. tuberculosis strains. This re-
gion contains multiple, well-conserved 36 bp (DRs) inter-
spersed with non-repetitive spacers of 34 to 41 bp. Members
of the MTBC and strains of M. tuberculosis vary in the num-
ber of DRs and in the absence or presence of particular spacers
[47]. The spacer regions can be lost over time, so this method
is suitable for investigating evolutionary aspects of human
tuberculosis and has also been used to clarify the origin and
transmission of this disease in different time periods and pop-
ulations. The MTBC can be assigned to four genotypic
groups, known as principal genetic groups (PCGs) (Table 1),
based on the combination of polymorphisms at codons 463
and 203 of the katG gene and codon 95 of the gyrA gene [43,
48].
Differentiation of the species of the MTBC can now be
performed by typing based on synonymous SNPs that are
functionally neutral, so can be used to distinguish between
lineages, aided by the lack of horizontal gene transfer. Initially,
SNP-based phylogenetic analysis of a global collection of
M. tuberculosis isolates classified the MTBC into six phylo-
genetically distinct groups, called lineages or SNP cluster
groups (SCGs), with a seventh group containing all M. bovis
isolates [49]. Subsequently, this led to the recognition of seven
phylogeographic lineages, each associated with specific hu-
man populations, with the animal lineages sometimes de-
scribed as lineage 8 [50]. The results of WGS [50] as well as
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genotyping and selected sequencing, for example, large se-
quence polymorphisms (LSP) [51], suggest that each lineage
is linked with a restricted geographical distribution. Lineage 1
occurs predominantly in the Philippines and Indian Ocean,
lineage 2 in East Asia and lineage 3 in India as well as East
Africa. In Europe and both Americas, lineage 4 is most likely
to be observed, while lineage 5 occurs mostly in West Africa
[51, 52]. Lineage 7 has, so far, only been observed in Ethiopia
and recent Ethiopian emigrants [53].
Methods of molecular identification and differentiation
of M. leprae
All extant isolates of M. leprae are nearly indistinguishable,
being derived from a single clone. TheM. leprae genome has
been shaped by reductive evolution and mass pseudogene
formation that has moulded its 3.31-Mb genome. Molecular
genotyping and sub-genotyping of M. leprae can be
performed using methods based on SNPs. All isolates of
M. leprae can be assigned to one of four SNP types deter-
mined by four combinations of three SNPs and 16 SNP sub-
types (Table 2) based on SNPs and InDel repeat sequences
[54, 55]. Due to being an uncultivable obligate pathogen, iso-
lates of M. leprae exhibit a strong relationship between their
SNP subtypes and geographical locations that reflects patterns
of early human migrations and trade routes, including the Silk
Road that linked Europe and China. Thereby, SNP typing
provides evidence for disease origins, dissemination and phy-
logeny [55].
Variable number tandem repeats (VNTR) typing is a meth-
od based on amplifying and sequencing of polymorphic mi-
crosatellite and minisatellite loci (short tandem repeat motif,
STR) present in theM. leprae genome. Its usefulness in mod-
ern cases is well proven. The rpoT locus (ML1022c) was the
first investigated VNTR locus in the M. leprae genome non-
coding region. Two variants of a 6-bp tandem repeat,
Table 1 Genetic groups of the MTBC based on the mutations in the katG and gyrA codons [43, 44, 48]
Genetic group
Gene codon 1A 1B 2 3
katG 463 CTG (Leu) CTG (Leu) CGG (Arg) CGG (Arg)
katG 203 ACT (Thr) ACC (Thr) ACC (Thr) ACC (Thr)
gyrA 95 ACC (Thr) ACC (Thr) ACC (Thr) AGC (Ser)
Member of MTBC MTBC precursor
M. africanum group A, M. bovis, M. microti
Ancestral
M. tuberculosis
M. africanum group B
M.tuberculosis M.tuberculosis
Fig. 2 Sequences in the TBD1
region received from strains of
different geographic regions [45]
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composed of GACATC, have been reported, one of four and
one of three tandem repeats [56]. TTC (AGA)20 locus
(ML2344–ML2345) polymorphisms were also identified
from the M. leprae genome sequence database. The number
of repeats at each locus may vary among M. leprae strains,
while most of the sequences in M. leprae seem to be con-
served. Sequence analysis of the TTC repeat region in each
of theM. leprae strains shows a variation of 10 to 37 repeats in
the non-coding region. The most reliable explanation of the
evolution of M. leprae strains with different numbers of TTC
repeats is slippage or addition of one codon during replication
[57, 58]. Latterly, over 40 potential variable loci (33
microsatellites and 11 minisatellites) have been identified.
Multiple loci variable number tandem repeats analysis
(MLVA) can be used for investigating cases within a limited
geographic area, to distinguish strains with the same SNP
profiles.
Use of molecular identification and differentiation in cases
of ancient tuberculosis
In the first paper published on the detection of ancient tuber-
culosis by molecular analysis, IS6110was the target used [17,
18]. In a significant early study in 2002, six cases dated to 7th–
8th century AD and eight cases dated to the 17th century AD,
from the collections housed at the Department of Anthropol-
ogy at the University of Szeged, Hungary, were screened [59].
All examined individuals exhibited signs of infection on the
bones. The presence of mycobacterial DNAwas investigated
by amplifying the gene encoding the 65 kDa antigen, although
this target is of doubtful use as it is found in all environmental
mycobacteria. However, the presence of MTBC DNA was
demonstrated by the amplification of a segment of the repet-
itive sequence IS6110. In several cases, the PCR product of
IS6110was treated withHaeIII to demonstrate MTBC typical
digestion products. Direct sequencing was applied to establish
the nucleotide sequences. The presence of mycobacterial
DNAwas confirmed in 13 cases, while IS6110 PCR was pos-
itive in eight cases [59].
In England, nine medieval human burials with signs of
tuberculosis, from Wharram Percy, were screened [60]. PCR
analysis of IS6110 and rpoB enabled verification of the paleo-
pathological diagnosis of tuberculosis. Conventional PCRs
for mtp-40, oxyR, pncA and the RD7 deletion were performed
to distinguish betweenM. tuberculosis andM. bovis. Since the
skeletal lesions of brucellosis may resemble those of tubercu-
losis, PCR analysis for Brucella DNA was also undertaken
with the use of the IS6501 multi-copy insertion element, var-
iable among species of Brucella (5–35 repeats in the genome)
but was negative. The results (Table 3) indicate that, in all nine
tuberculosis cases fromWharram Percy,M. tuberculosisDNA
rather than M. bovis DNA was present. Spoligotyping was
also used here to detect and type members of the MTBC. This
can also elucidate the origin and transmission of the pathogen
in different time periods and populations [61].
In ancient Egypt, Zink and colleagues reported their anal-
ysis of bone and tissue samples from 85 Egyptian mummies,
dated to 2050–500 BC, found in different tomb complexes of
West Thebes, Upper Egypt [61]. Samples were screened for
the presence ofMTBCDNA, using IS6110 PCR. Those yield-
ing positive results for Mbov, mtp-40 and the oxyR regions
were amplified to differentiate between M. tuberculosis and
M. bovis. Furthermore, in those samples, spoligotyping was
used for the subsequent analysis of M. tuberculosis DNA.
IS6110 PCR confirmed the presence of MTBC DNA in 25
samples, although PCRmethods to distinguishM. tuberculosis
from M. bovis gave inconclusive results, as summarised in
Table 4. Although five modern samples were positive with
the M. bovis-specific primers, only two ancient samples were
successfully amplified for mtp-40. The oxyR gene was detect-
ed in only three ancient samples.
During spoligotyping, due to the degradation of the aDNA,
all blots were performed in triplicate. Reproducible patterns
were obtained from 12 individuals and compared to those in
the international spoligotyping database. Three isolates
matched types 53, 393 and 291 from the database and are
close or identical to the ubiquitous M. tuberculosis type 53.
Type 53 represents one of the most common profiles. Five
Table 2 M. leprae SNP types by Monot et al. [54, 55]
SNP type
1 2 3 4
Position in genome
14676 C C C T
1642875 G T T T
2935685 A A C C
Subtypes A, B, C, D E, F, G, H I, J, K, L, M N, O, P
Present occurrence Asia, the Pacific region,
East Africa






Eur J Clin Microbiol Infect Dis (2015) 34:1733–1749 1737
samples showed a pattern similar to that of M. africanum.
Others were not found in the database, but all of them were
related to the M. tuberculosis TbD1-deleted type, suggested
by the lack of spacers 33 to 36 and the presence of spacers
between position 39 to 45. Patterns suggestive for M. bovis
were not found in any of the examined samples. This study is
an early example of paleoepidemiology and was made possi-
ble by the excellent preservation of the skeletal material in
Ancient Egypt [62, 63].
A remarkable collection of 263 naturally mummified bod-
ies was discovered in an 18th century AD Hungarian crypt in
Vác, Hungary in 1994–1995. In many cases, there were archi-
val records giving details of name, family connections, date of
death and, occasionally, information on occupation or symp-
toms. Because of the local environmental conditions, the hu-
man remains were in an excellent state of preservation. In an
initial study [64], 350 samples from 168 individuals were
examined. A two-tube nested PCR of the IS6110 insertion
sequence was used in the initial screening. Polymorphisms
at codon 463 of katG and codon 95 of gyrAwere assessed in
order to place the strains into genotypic groups [43]. Methods
specific for M. tuberculosis were positive in 55 % of the
Table 4 Results of PCR-based
differentiation between
M. tuberculosis andM. bovis [62]
M.bovis mtp-40-1/2 mtp-40-3/4 oxyR IS6110 Spoligotyping
Modern control DNA
Mtb H37Rv (10 ng/μl) + + + + + Mtb
Mb BCG (10 ng/μl) + + + + + Mb
Mtb H37Rv (0.1 ng/μl) − + + + + Mtb
Mb BCG (0.1 ng/μl) + − + + + Mb
Recent autopsy cases
Paraffin sample Mb + − − − + Mb
Paraffin sample Mtb − − − − + Mtb
Historic tissue samples
TT453-9 + − − − + Mtb
TT453-14 + − − − + Mtb
TT95-122 + − − + + Mtb
TT95-40 − − − + + Mtb
TT95-169 − − − − + Mtb
DAN93-11 + + − − + Mtb
DAN95.1-1 + − + + + Mtb
TT196-M5 − − − − + Mafr
− = no result; + = positive result; Mtb = M. tuberculosis; Mb = M. bovis; Mafr = M. africanum
Table 3 Genotyping of nine
medieval individuals with signs
of tuberculosis from Wharram
Percy [60]
IS6110 rpoB mtp-40 oxyR pncA RD7 deletion Spoligotyping IS6501a
Controls
EE003 − − nd nd nd nd nd nd
G304 − − nd nd nd nd nd nd
Samples
EE056 + + + − nd nd − −
G438 + + + + (G) nd − nd −
G482 + + + + (G) nd − − −
NA026 + + − + (G) nd − Mtb −
NA046 + nd − + (G) nd − Mtb −
NA112 − + + + (G) nd nd Mtb −
NA197 + + + − nd − − −
SA013 − + + + (G) nd − − −
WCO142 + + + − nd − − −
− = no result; + = positive result; nd = not determined
aBrucella-specific insertions (5–35 repeats in the genome)
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samples. Initial PCR-based genotyping showed that two sam-
ples were classified as PGG2, five samples were classified as
PGG3, while five other samples were classified as not PGG1
but either genetic groups 2 or 3 based on the polymorphic
regions of the katG and gyrA genes. Samples from three indi-
viduals in a family group were analysed further using PCR for
mtp-40, oxyR, plcD, MT18101-plcD, as well as the RD7 de-
letion, in an attempt to distinguish M. tuberculosis from
M. bovis. Molecular fingerprinting of the MTBC DNA was
carried out using spoligotyping. The results of the oxyR
pseudogene (guanine at position 185), mtp-40 (positive),
plcD-cutinase (positive) and RD7 (no product obtained) indi-
cated the presence of M. tuberculosis rather than M. bovis
DNA. Moreover, spoligotyping patterns obtained from all
samples demonstrated the presence of M. tuberculosis DNA:
one sample matchedM. tuberculosis type 53 and two samples
matched the profile ofM. tuberculosis type 50 [65]. One of the
individuals in this family group gave excellent results in a
recent study based on shotgun sequencing and WGS [34]. A
follow-up study based on 26 bodies from the Vác crypt dem-
onstrated that all were of lineage 4, associated with European
populations. Eight individuals were examined in depth and
five had mixed M. tuberculosis infections with two, or in
one case, three strains of different sub-lineages [66].
In 2003, Mays and Taylor described a case of tuberculosis
from prehistoric times, which may be the oldest from Britain.
They investigated remains excavated at the archeological site
in Tarrant Hinton, England dated to 400–230 BC, which
belonged to an individual suffering from an infectious disease,
most likely tuberculosis. Nested PCR of the multi-copy ele-
ment IS6110was performed in an attempt to confirm the pres-
ence of MTBC DNA and, hence, the diagnosis of tuberculo-
sis. Four separate DNA extracts were prepared from bone
powder sampled from vertebrae and ribs, and three of them
were positive. Furthermore, two extracts of DNA from burials
without any evidence of infection, which were studied as con-
trol samples, yielded negative results. PCR analysis for
Brucella DNA was also undertaken using the IS6501 multi-
copy insertion element. Samples positive for MTBC DNA
were further examined for polymorphisms using the oxyR
pseudogene and the RD7 deletion, to distinguish M. bovis,
M. africanum and M. microti from M. tuberculosis. In an
attempt to provide information about the genotypic group,
extracts were analysed for polymorphic sites in the katG
463, katG 203 and gyrA loci. Only one marker, IS6110, was
efficiently amplified, probably due to the poor degree of DNA
preservation [67]. This same case was re-examined in 2005
[39] in order to determine whether the Tarrant Hinton individ-
ual had suffered from tuberculosis due to M. tuberculosis or
M. bovis and to perform further genotypic analysis of the Iron
Age strain. To confirm that extracts prepared for this study
were also positive for MTBC DNA, nested PCR for IS6110
was carried out. Amplification of the IS1081 sequence yielded
positive results. Furthermore, two loci frequently used for dif-
ferentiation between M. tuberculosis and M. bovis strains
(oxyR and pncA) were analysed and gave positive results.
Sequencing of the obtained PCR products showed guanine
at position 285 (oxyR locus) and adenine at position 169
(pncA). Both results confirmed that M. tuberculosis DNA
rather thanM. bovisDNAwas present in the analysed sample.
TheM. tuberculosisD1 deletion locus was also examined and
identified the strain as a ‘modern’ TbD1-deleted
M. tuberculosis isolate [39].
Ten samples from 18th century burials in Kaiserebersdorf
Castle in Austria, now in the collection at the Natural History
Museum Department of Anthropology in Vienna, Austria
were investigated for the presence of MTBC DNA. Three
bone samples from the anatomical ‘Weisbach collection’were
used as positive controls and two bone samples from a site at
Hainburg were used as negative controls. PCR amplifications
targeting IS6110, IS1081, oxyR, pncA and TbD1 regions of
MTBCDNA, followed by cloning and DNA sequencing were
performed. Despite the fact that PCR products of appropriate
size were obtained for several bone samples, only PCR
targeting the IS6110 region in one sample yielded a product
with a sequence identical to the reference IS6110 insertion
sequence ofM. tuberculosis. Other PCR products were likely
the results of non-specific PCR amplification. This failure to
obtain a positive diagnosis ofM. tuberculosis DNA in human
remains was probably due to the poor aDNA preservation
status of these bones frommuseum collections [68]. The pres-
ervation of the aDNA in a sample is not related to its age but to
the local environmental conditions over time. For example,
IS6110, together with the repetitive element IS1081, was suc-
cessfully used in the molecular analysis of Neolithic skeletons
(5400–4800 BC) from central Germany [14] and Hungary [6],
dating from 4970–4490 BC.
Bouwman et al. used an NGS approach which involved
hybridisation capture directed at specific polymorphic frag-
ments of theM. tuberculosis genome, as well as a convention-
al PCR approach, to genotype a historic strain of
M. tuberculosis from an individual dated to the 19th century
AD, originating from St. George’s Crypt in Leeds,West York-
shire, England. The SNP data obtained enabled a comparison
between this strain and extant isolates ofM. tuberculosis. This
enabled the assignment of the historic strain into lineage II,
SCG 6b and SNP type (ST) 14 or 40. Thirteen loci success-
fully typed by the conventional PCR approach confirmed the
accuracy of the NGS results, demonstrating that NGS is a
valuable method that can be used in investigating ancient va-
rieties of M. tuberculosis [31].
In 2014, Müller et al. carried out a biomolecular analysis of
MTBC DNA isolated from the remains of individuals living
between the 1st and 19th centuries AD found at 29 British
sites (59 samples) and eight continental European sites (11
samples). Both IS1081 quantitative PCR and IS6110 PCR
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were performed on each sample. Twelve samples definitely
contained MTBC DNA (IS6110 PCR was positive in at least
two extracts). However, the diagnosis of a further 22 cases
was described as probable or possibly containing DNA of
the MTBC (IS6110 PCR or IS1081 real-time PCR positive
in one of the extracts). Forty-three other samples produced
no amplicons from any of the targeted sequences [69].
Thirty-four bone and dental samples from 31 individuals with
positive results of IS6110 and IS1081 PCRs were
characterised further. Conventional PCR of 11 SNPs and
two LSPs was performed in an attempt to classify MTBC
strains into 1–3 principal genetic groups (PGGs; gyrA 284,
katG 1388), I–IV lineages and M. bovis (oxyR 37, oxyR 285,
rpoB 2646, rpoB 3243), 1–7 SCGs (leuB, qcrB, recN,
Rv0083, Rv2802c), ‘modern’ M. tuberculosis (TbD1-
deleted) and the Euro-American lineage of modern
M. tuberculosis (pks15/1-deleted). Data obtained from ten
samples allowed categorisation of the MTBC according to
their SNP identities, appearance of the TbD1 locus and/or
the occurrence of deletion within pks15/1. PCGs and SCGs
were successfully defined in two independent extracts from
six samples. The results are summarised in Table 5 [70].
Although recent studies have investigated whether human
cases of tuberculosis have been caused by M. bovis, there is
only one good example from Iron-Age south Siberia, where
semi-nomadic pastoralists overwintered with their animals
[71]. This was diagnosed by a genotypic analysis of the
aDNA using PCR based on regions of difference (RD) sites.
In another and unexpected finding, the use of NGS has
revealed that 1000-year-old pre-Columbian Peruvian human
skeletons were infected with a member of the MTBC that
appears to be M. pinnipedii, which is normally associated
with sea mammals. This raises many questions but it is
suggested that these individuals, who lived by a river that
flows to the Pacific Ocean, may have become infected by
contact with seals [72].
In summary, it is clear that the detection and characterisa-
tion of aDNA from M. tuberculosis, M. bovis and the MTBC
is well advanced, in line with the strong interest in the modern
disease.
Figure 3 shows molecularly investigated ancient MTBC
cases presented in this review.
Molecular investigations of ancient leprosy
The first case of ancient leprosy to be subjected to molecular
examination, dating from the first millennium, was obtained
from a leprosarium, now in modern Israel [23, 24]. the results
were initially queried, as the PCR target region was for a 530-
bp target in the 36 kDa antigen locus. It was thought to be too
large, but recent studies illustrate the remarkable preservation
ofM. leprae aDNA in some samples [33]. Another individual
case of leprosy investigated by this group used PCR as paleo-
pathologists could not agree on the cause of the visible bony
lesions [73]. Meanwhile, Haas et al. fromMünich undertook a
molecular study of leprosy from a 10th century cemetery in
Hungary and a South German ossuary of a later date [74],
basing their samples on bone paleopathology. M. leprae
DNA was amplified and sequenced. In addition, evidence
was obtained of M. tuberculosis in another specimen.
The first recognised case of leprosy in Mediaeval Poland,
from Suraż, dated to the 12th–14th centuries AD [4]. This case
was included in a molecular study alongside archaeological
samples with lesions from Hungary (one sample dated to
14th–15th century AD and two samples dated to 10th–11th
century AD).M. leprae nested PCR for the specific repetitive
element RLEP (36 copies per cell) and the 18 kDa antigen
gene (single copy per cell), followed by DNA sequencing,
were used to detect the target aDNA. This was successfully
achieved using extracts from cavum nasale samples [75].
The first British case of leprosy to be subjected to molecu-
lar analysis, for the RLEP region, was from a mid-10th
Table 5 Results of ancient
M. tuberculosis genotyping
obtained in Manchester and
Madrid from two independent
extracts [70]
TbD1 pks15/1 PGG Lineage SGG
Sample
Ashburch 705 −/− +/+ 2 or 3/2 I or II/nd 3/3 or 4
Auldhame 43 −/× +/+ 2/2 II/nd 5/5
Saint Amé 20 nd/× nd/+ 3/3 Not IV/not III 6/6
St. George’s Crypt 4006 −/− +/+ 3/3 II/II 6/6
St. George’s Crypt 5003 nd/− +/nd nd/nd Not IV/nd 6/nd
St. Peter’s Church 1390 −/× +/+ 2/2 I or II/nd 3/3
St. Peter’s Collegiate Church 28 −/× +/nd 3/nd I or II/nd 6/nd
St. Peter’s Collegiate Church 62 −/− +/+ 2/2 I or II/II 4/4
Whitefriars 657 nd/× +/nd 2/3 I or II/nd 6/6
Whitefriars 10466 −/× nd/+ 2/2 I or II/nd 4/4
− = deletion of TbD1 has occurred; + = 7-bp deletion in pks15/1 has occurred; nd = not determined; × = not
analysed
1740 Eur J Clin Microbiol Infect Dis (2015) 34:1733–1749
century burial in a Norse Christian cemetery in Orkney, Scot-
land [76]. In 2006, Taylor et al. examined two individuals,
with demonstrable osteological evidence of lepromatous lep-
rosy, from two English Mediaeval sites: Wharram Percy,
Yorkshire (burial G708 radiocarbon dated to 960–1100 AD)
and Blackfriars Friary, at Ipswich, Suffolk (burial 1914 radio-
carbon dated to 1263–1538 AD). Again, the sensitive
multicopy RLEP PCR was used to confirm the presence of
M. leprae DNA and both burials were found to be positive.
VNTR typing was used to assess genetic variability between
strains in these cases and also a modern reference strain of
M. leprae. The microsatellite regions, AGT and TTC, and
one minisatellite region containing exact copies of a 21-bp
repeat, were genotyped. The VNTR analysis (Table 6) and
genotyping demonstrates differences between modern and
historicalM. leprae and between the two strains from investi-
gated burials [77].
Watson et al. sought evidence ofM. lepraeDNA in ancient
European remains from Croatia, Denmark and the UK. They
were dated to 476–1350 AD and examined by RLEP PCR and
SNP typing. RLEP PCR was positive in three samples from
the UK, one sample from Denmark and two samples from
Croatia. DNA extracts that were positive for the RLEP se-
quence were further typed. All examined samples were of
SNP type 3 [78] (corrected 2010 [79]). The genotyping study
of both modern and ancient strains ofM. leprae [55] identified
the Hungarian strains as genotype 3K or 3M. In 2011, Taylor
and Donoghue used three variable VNTR loci, AGT, TTC and
21–3, to characterise M. leprae from five archeological sites
with a confirmed presence ofM. lepraeDNA and known SNP
types and subtypes: Hungary, cases 503 and 222 (10th centu-
ry), KD271 (7th century); the Czech Republic, burial 188
(9th–10th century) and northern Byzantine Turkey, KK ’02
20/1 (8th–9th century). All the examined samples were found
to have distinct MLVA profiles. Furthermore, an individual
(burial 1914, 13th–16th century) from Ipswich, Suffolk [77]
was genotyped as SNP subtype 3I [80]. The 2006 study [77]
also confirmed that a leprosy case from Uzbekistan, dated to
the 1st–4th centuries AD, was of genotype 3 L, the only
known example from aDNA analysis.
Fig. 3 Examples of analytical
methods used to identify MTBC
aDNA in selected European sites
Table 6 VNTR typing of two
medieval leprosy cases from
Wharram Percy and Blackfriars
Friary compared to modern
leprosy DNA [77]
Individual from Wharram Percy Individual from Blackfriars Friary Modern DNA
Number of repeats
AGT 8 9 10
TTC 10 12 13
21-bp repeat 3 2 2
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Rubini et al. examined two cases of childhood leprosy from
the ancient Roman and Byzantine Empire. The first case was a
skeleton of a 4–5-year-old child from a Roman cemetery at
Martellona dated to the 2nd–3rd centuries AD. The second
case, a 4–5-month-old infant was from a burial at
Kovuklukaya in northern Byzantine Turkey, as mentioned
above. Both skeletons exhibited bony changes indicative of
leprosy. RLEP PCRwas positive only for the second case and,
at present, it is the youngest individual in the world proved to
have suffered from leprosy in the past [81].
An early molecular study of leprosy in Sweden [82] dem-
onstratedM. leprae aDNA from the Viking era. Subsequently,
Economou et al. examined ten skeletons, from two cemeteries
in Sigtuna, Sweden dated to the 9th–13th century AD, for
M. leprae genomic sequences. Eight of those individuals
had formerly been described as exhibiting bone changes char-
acteristic for leprosy. RLEP PCR analysis was performed and
nine specimens were positive for the repetitive RLEP element.
SNP typing was possible in three samples: one was
characterised as SNP type 3I and two as SNP type 2F. The
remaining specimens either yielded no amplicons or results
for one or two loci only. SNP type 3I has been described in
a number of cases from ancient Europe. SNP type 2F had
never been reported in Europe before and was previously con-
sidered as Asian [83]. Taylor et al. sampled nine skeletons
showing good osteological signs of leprosy and bone preser-
vation, originating from the St. Mary Magdalene leprosy hos-
pital site in Winchester, UK. Two skeletons with no signs of
leprosy were also sampled as negative controls. The presence
of M. leprae DNAwas investigated using the multicopy ele-
ment RLEP, as well as the single copy 18 kDa antigen gene.
Samples were subsequently characterised by SNP and MLVA
typing. The results of M. leprae fingerprinting are shown in
Table 7. Two SNP types were obtained during studies: 3I-1
and 2F. SNP type 3I-1 has been observed previously in the UK
and confirms the association of SNP type 3 strains with Eu-
rope. However, SNP type 2F has never been described in the
UK before and has formerly been reported in Asia and lately
in Scandinavia [84]. Other cases from England and Scandina-
via also appear to be predominantly of genotypes 2F or 3I [33,
85], suggesting that SNP types 2 and 3 co-existed in Mediae-
val Europe.
DNA bead capture and high-throughput sequencing (NGS)
were used by Schuenemann et al. to obtain complete genome
sequences of M. leprae from skeletons from five Mediaeval
archeological sites in the UK, Sweden and Denmark. These
were compared with 11 modern strains. Bayesian phylogeny
inference, maximum likelihood, neighbour joining and maxi-
mum parsimony were used to calculate the phylogenetic trees
of all genomes. The majority of the examined strains clustered
into four major branches supported by bootstrap values of
>90 % for all major nodes. This is consistent with the SNP
typing scheme. Two modern strains had the deepest lineage
and formed a new branch 0. One modern strain displayed deep
divergence and did not fit definitely into one branch. These
three different strains were found to be those closest to the
suggested common ancestor of M. tuberculosis, M. leprae,
M. avium and M. ulcerans. The nucleotide distance of 16
sequences to the reconstructed most recent common ancestor
(MRCA) of all M. leprae strains was calculated in an attempt
to verify if the ancientM. leprae strains have shorter branches
in a phylogenetic tree compared to the modern branches. The
average distance to theMRCA for the ancient strains was 19.8
nucleotides and for the modern strains it was 27.5 nucleotides.
Table 7 Genotyping of nine
individuals from the St. Mary
Magdalene leprosy hospital site in
Winchester, UK [84]
RLEP 18 kDa antigen SNP typing MLVA typing
AGA(20) (GTA)9 21-3 loci IS1081*
Negative control
Sk1 − − × × × × −
Sk12 − − × × × × −
Samples
Sk2 + + 3I-1 11 8 2 −
Sk7 + +* 3I-1 13 8 2 −
Sk8 + + 2F 14 8 2 −
Sk9 +* − × × × × −
Sk14 + + 2F 14 8 2 −
Sk15 +* − × × × × −
Sk18 +* − × × × × −
Sk19 + +* 3I-1 14 7 Fail −
Sk23 +* +* × × × × −
− = no result; + = positive result; +* = weakly positive result; × = no analysis was done
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The ancient strains displayed significantly shorter branches in
the tree. Strains assigned to branch 2 formed a tight cluster
with very short branch lengths. Branch 3 strains are found in
European ancient samples and inmodern samples fromAmer-
ica, indicating the European origin of leprosy in the Americas.
SNP subtyping was performed also for individuals from 11th–
14th century AD, Denmark and assigned to 3I and 2F groups,
the same as that reported by others [33, 83, 84]. Variations in
theM. leprae subtype 3I have been found [84] and, in a recent
study of a 5th–6th century male from Essex, East England [86],
the authors suggest that thisM. leprae strain was ancestral to the
Mediaeval strains and may have originated in Scandinavia.
Using collated evidence of the distribution of M. leprae in
ancient and historical Europe, based on genotyping where pos-
sible, Donoghue et al. have suggested that the differences be-
tween subtypes in central and east Europe, compared with
northwest Europe, may be linked to human migration [5].
All molecularly investigated cases of ancient leprosy de-
scribed in the review are presented in Fig. 4.
Significance of the host genome in mycobacterial
diseases
Investigation of the aDNA from human pathogens enables the
assessment of disease epidemiology in past millennia. Develop-
ment of mycobacterial diseases, as for many other infectious con-
ditions, depends on both environmental and genetic factors, i.e.
host and pathogen genomes. Only about 10 % of carriers of
M. tuberculosis develop the disease, thereby indicating the impor-
tance of alleles coding for resistance in the formation of a
pathogen-resistant phenotype [87]. However, it should also be
remembered that other non-genetic factors influence human sus-
ceptibility to infection, such as co-morbidity, co-infections, dietary
deficiencies, stress and trauma [88]. The significance of the host
genome in the development of mycobacterial diseases has been
confirmed by studies on mono- and di-zygotic twins and by doc-
umented differences in disease incidence around the world, cor-
relatedwith the history of the disease in different regions [89]. The
immunological resistance to leprosy and tuberculosis has devel-
oped under strong selective pressures, such as epidemics, which
have promoted the survival of the best-adapted individuals and
changed the composition of the gene pool, i.e. increased the fre-
quency of resistance-related alleles. Therefore, the presence of
pathogens in human populations has left a strong mark and the
differences between ancient and present gene pools can elucidate
the course of major epidemics and help resolve any doubts about
the time of disease origin. Moreover, studies based on changes in
the frequency of resistance-related alleles provide information
about whole populations rather than individuals, where data are
gained by the examination of pathological bone lesions. A
broader paleopathological approach that combines population ge-
netics with the molecular analysis of pathogens responsible for
infectious disease constitutes a promising tool of much greater
power in reconstructing human history rather than using a
single-approach analysis.
Fig. 4 Examples of analytical
methods used to identify
M. leprae aDNA in selected
European sites
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Genes involved in genetic predisposition to leprosy
and tuberculosis
Genetic predisposition to tuberculosis and leprosy is still a
subject of extensive investigation due to the complexity of
reactions induced by mycobacteria. Owing to intensive re-
search including family-based and case–control studies, sev-
eral polymorphisms can be linked to mycobacterial diseases.
Candidate genes linked to a tuberculosis-susceptible genotype
involve a great number of immunological response compo-
nents, such as cytokines, chemokines and receptors. However,
some genes with influence on tuberculosis development are
well investigated and confirmed. Examples are genetic alleles
of mannose-binding lectin (MBL2), interleukins (IL1, IL6,
IL8, IL10), interferon (IFNG), receptors (PR2X7, TLR1,
TLR2) and human leukocyte antigens [87, 90, 91]. Neverthe-
less, the strongest evidence for genetic susceptibility to both
tuberculosis and leprosy is based on the solute carrier family
11 SLC11A1, formerly known as natural resistance-associated
macrophage protein 1 (NRMAP1) [92]. It encodes a divalent
cation transporter build of 550 amino acids which is recruited
to the phagolysosomal membrane during phagocytosis in
macrophages and neutrophils [93].
Killer cell immunoglobulin-like receptors (KIRs) are mem-
bers of a group of regulatory molecules found on subsets of
lymphoid cells, first identified by their ability to impart some
specificity on natural killer (NK) cytolysis. The KIR locus,
which maps to chromosome 19q(13.4) within the 1 Mb leu-
kocyte receptor complex (LRC), contains a family of poly-
morphic and highly homologous genes. The KIR molecules
recognise the human leukocyte antigen (HLA) class I mole-
cules, which are encoded by genes within the major histocom-
patibility complex (MHC) chromosome 6 [94]. Interactions
occur between KIR isotypes that inhibit NK cell activity. Re-
cent studies report a greater repertoire of inhibitory KIR genes
among tuberculosis patients than controls [95] and a direct
association of certain KIR and HLA-C genes [96] with resis-
tance to pulmonary tuberculosis.
Several SLC11A1 polymorphisms (e.g. 3′UTR, D543N, 5′
(GT)n, INT4) have been linked to host genetic predisposition
to both leprosy and tuberculosis in various populations, mak-
ing it a common rather than a local susceptibility-related gene.
To estimate the role of this ion transporter in forming resistant
genotypes, Barnes et al. [97] determined the frequency of one
allele (SLC11A1 1729 + 55del4) in various populations from
global cities with a different length of time since urbanisation.
Interestingly, in longer-term urbanised populations, the inci-
dence of the protective allele was significantly higher as a
result of natural selection. Their studies support the thesis that
urbanisation and population density determine the general
health status of the population and influence its genetic struc-
ture. Moreover, an initial study on the comparison of allele
frequencies (SLC11A1, MBL2) that formed part of a Ph.D.
dissertation revealed interesting discrepancies between medi-
eval and contemporary Polish populations [98]. Samples from
various 11th–14th century archaeological sites displayed a
consistent pattern of a significantly higher frequency of alleles
predisposing to infectious diseases compared with the con-
temporary Polish population. The results point to a positive
selection of protective variants over time, most probably due
to past epidemics.
Susceptibility to leprosy depends on various mutations
within several genes, for example, the major histocompatibil-
ity complex (HLA-DR, HLA-DQ), tumour necrosis factor α
(TNFA), Toll-like receptors (TLR1, TLR2, TLR4, TLR9), vita-
min D receptor (VDR) or cytotoxic T cell antigen 4 (CTLA4),
among others [89, 99, 100]. However, the predisposition to
mycobacterial diseases depends upon the ethnic group, which
makes it difficult to determine one genotype responsible for
susceptibility to leprosy. The best-described leprosy-related
genetic markers are regulatory polymorphisms within PARK2/
PACRG genes. Even though the function of the Parkin gene is
still unknown, it has been proved that two polymorphisms
within the 6q25 locus are involved in susceptibility to
paucibacillary and multibacillary leprosy [101, 102]. Bakija-
Konsuo et al. measured the frequency of selected changes in
the isolated population of Mljet island in Croatia, used in the
past to quarantine for leprosy patients, and compared it with
the reference populations with no history of leprosy [103].
They found a significant increase in the frequency of both
protective alleles, indicating their positive selection in the
course of high disease prevalence and demonstrating the im-
portance of host genotype and changes in population gene
pools under high selective pressure.
According to John Haldane, 1949, cited by Bellamy in
2005 [90], pathogens have been the major agents for natural
selection over the last 5000 years. He suggested that natural
selection was driven mainly by the necessity to resist patho-
gens, as they were the main cause of premature deaths in the
past [90]. Between the 18th and 19th centuries, during the
Industrial Revolution in Europe, fast development and the
human population explosion, as well as the probable increase
of pathogen virulence, initiated a huge increase in tuberculo-
sis, which caused one-fifth of all deaths. The low incidence of
tuberculosis in Europe in the recent past indicates that the
development of tuberculosis depends predominantly on the
host genome rather than the pathogen. Therefore, the frequen-
cies of selected alleles that predispose to tuberculosis and lep-
rosy among past populations of different ages could elucidate
the susceptibility/resistance status of selected populations and,
thus, the presence of pathogenic mycobacteria in that period.
Even though the history of both tuberculosis and leprosy is
moderately understood, there are still many aspects that re-
quire resolution, including the time of the emergence of these
mycobacterial diseases in Europe. The comparison of various
populations can provide data about the dynamics of change
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and distinguish the role of each allele in the process of resis-
tant phenotype formation. Thus, further research on host
genes related to susceptibility/resistance to mycobacterial dis-
eases is crucial in order to identify the mycobacterial resistant
genotype in different populations and enabling the recognition
of changes in allele frequencies. Extending this to aDNA stud-
ies, limited data are now available for amplified aDNA from
18 individuals from the 18th century Vác, Hungary and early
Christian Nubia [88].
Other applications of susceptibility studies
Research on genetic susceptibility among ancient populations
complements work on paleoepidemiology. These have mainly
focused on the pathogen, and have already been successfully
employed in several studies. In 2006, Witas et al. assessed the
frequency of the Δ32-CCR5 mutation in a medieval Polish
population and compared it with the contemporary gene pool
[104, 105]. The deletion of a 32-bp sequence in the coding
region of this chemokine receptor leads to the perturbation of
its fusion to the cell membrane [106]. The lack of two functional
copies of the CCR5 gene results in the absence of the leucocyte
surface receptor and results in a strong but incomplete resistance
to HIV-1 infection. The area of mutation occurrence is restricted
mainly to Europe and parts of Asia. Its frequency in Europe
varies according to the region, from 4 % in Sardinia to 15 %
in Finland [107]. In present-day Poland, the incidence is similar
to the European average of 10.9% [108]. However, the frequen-
cy of this protective allele in the medieval Polish population
(11th–14th century) was half as great (5.06 %), which may
signal the positive selection due to the protecting allele during
this time period [104, 105]. These results conflict with the alter-
native suggestion that Yersinia pestis was a selective factor for
Δ32-CCR5, as the timing of plague epidemics does not match
the likely emergence of the deletion and the origin of this mu-
tation remains unsolved. Meanwhile, Fontecchio et al. have
attempted to answer the question about the susceptibility to
rheumatoid arthritis (RA) in the decay of the Middle Ages. It
is commonly believed that the disease was brought to Europe
from America at the end of the 15th century. The genetic pre-
disposition to RA, based on the polymorphic HLA-DRB1 locus,
which was carried by an early case known as the ‘Braids Lady’
from Arezzo (Italy), combined with pathomorphological lesions
characteristic for this condition. This confirms the presence of
RA in the Old World in the mid-16th century and brings us
closer to answering the question about the worldwide diffusion
of rheumatoid arthritis [109].
Summary
Emerging molecular approaches employed in the investiga-
tion of M. tuberculosis and M. leprae in ancient human
remains began a new era of paleopathological analysis. The
techniques described have been applied successfully in sever-
al European studies, revolutionised the classical approach to
ancient disease studies and accelerated the development of
paleomicrobiology. As the molecular analysis of bacteria from
ancient material has become widespread, it is possible to de-
termine their phylogenetic affiliation. Therefore, studies of
bacteria from different times and locations will undoubtedly
enable a better understanding of the origin of infectious dis-
eases. The novel techniques of aDNA sequencing have en-
abled the identification of genes related to susceptibility and
resistance phenotypes within ancient populations, which may
be an important factor in the determination of past bacterial
prevalence. Methods have been reviewed and changes in pop-
ulation immunological profiles over time are assessed. The
overall aim is to reach a better understanding of the history
of tuberculosis and leprosy and to determine the timescale of
major outbreaks. However, the complexity of the immune
response induced by mycobacterial infections, such as the
great number of gene polymorphisms involved in host suscep-
tibility, constitutes a major problem in employing such
methods in paleoepidemiology. Nevertheless, the progress in
elucidating host genetic profiles, linked to the predisposition
of susceptibility or resistance to infection, is enabling a better
understanding of the course of two major historical diseases in
the human population.
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